Skip to content

Supplementary Neuromuscular Rehabilitation During Acute Concussion Recovery

Supplementary Neuromuscular Rehabilitation During Acute Concussion Recovery

Status
Not yet recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07801482
Enrollment
30
Registered
2026-09-03
Start date
2027-08-02
Completion date
2030-07-31
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concussion (Diagnosis), Gait Abnormality

Keywords

brain concussion, gait, symptom burden

Brief summary

Approximately 1.6 to 3.8 million mild traumatic brain injuries, or concussions, occur yearly in the United States. Although most individuals progress through return-to-activity (RTA) using symptom-guided aerobic and functional activity, current protocols do not directly target neuromuscular deficits linked to persistent movement alterations after concussion. These deficits include altered gait, reduced movement efficiency, and biomechanical changes that persist beyond symptom resolution and increase subsequent risk of musculoskeletal injury. This creates a critical clinical gap: patients are cleared using symptom-tolerance protocols, while concussion-related neuromuscular impairments remain untreated during the period when recovery behaviors are established. The proposed project addresses this gap by testing a low-cost, equipment-free neuromuscular rehabilitation strategy added to standard RTA during acute concussion recovery. The intervention applies the six principles of clinical Pilates, concentration, control, centering, precision, flow, and breathing, through ten therapeutic movements designed to improve posture, flexibility, balance, strength, muscle control, body awareness, and movement confidence.

Interventions

BEHAVIORALExercise

The intervention will include 10 standardized exercises: pelvic tilts, bridging, seated spinal twists, bent-knee fallouts, supine toe taps, clamshells, side-lying leg lifts, supine side-to-sides, quadruped arm and leg reach, and standing roll downs. Not every exercise will be performed during every session. Exercise selection will follow a prespecified intervention framework designed to provide consistent exposure to the major movement domains of the protocol while permitting symptom-guided modification. The standardized protocol will identify the exercises eligible for each stage of progression and the criteria required to advance to more demanding movements. Research personnel will select exercises from the appropriate stage based on the participant's current tolerance, symptom response, movement quality, and prior session performance.

BEHAVIORALReturn to Activity Progression

A research team member will attend each RTA session to collect symptom ratings immediately before and after the session. Assessments will occur whenever the athlete completes an RTA session, up to five days per week, between days 7 and 35 after concussion. These repeated observations will characterize symptom response to standard RTA throughout recovery.

Sponsors

Northern Illinois University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

* aged 18 to 24 years old * be a registered member of an intercollegiate sports team * have received a medically confirmed concussion within 7 days of the initial study visit.

Exclusion criteria

* moderate or severe traumatic brain injury * red-flag signs or symptoms requiring urgent medical evaluation * current lower-extremity injury that prevents safe walking or therapeutic exercise * a neurological or vestibular disorder unrelated to concussion that independently affects balance or gait * an uncorrected visual impairment that prevents completion of testing * any medical condition that prevents participation in symptom-guided physical activity

Design outcomes

Primary

MeasureTime frameDescription
Symptom BurdenDay 7 to 35Symptom Burdent
Tandem Gait PerformanceDay 7 to 35Tandem Gait time to complete
Recovery TimeDay 7 to 35Time to Recovery

Countries

United States

Contacts

CONTACTTyler A Wood, PhD, LAT, ATC
twood1@niu.edu815-753-1418

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026